Modulation of neuroglia-derived BDNF in the treatment and prevention of pain
US8187823B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 30, 2005 |
| Grant date | May 29, 2012 |
| Priority date | — |
| Expiry date | Nov 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and products for the attenuation or treatment of pain and the reduction of nociception are described. The methods and products are based on the modulation of neuroglia-derived BDNF expression or activity. Also described herein are commercial packages and uses based on such modulation. Related methods for identifying or characterizing compounds for the treatment of pain and the reduction of nociception are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.